On Friday, Jasper Therapeutics Inc (NASDAQ: JSPR) opened higher 6.01% from the last session, before settling in for the closing price of $2.33. Price fluctuations for JSPR have ranged from $2.21 to $26.05 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 54.53% annually for the last half of the decade. Company’s average yearly earnings per share was noted 10.28% at the time writing. With a float of $23.85 million, this company’s outstanding shares have now reached $27.92 million.
Jasper Therapeutics Inc (JSPR) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Jasper Therapeutics Inc is 14.58%, while institutional ownership is 42.40%. The most recent insider transaction that took place on Sep 22 ’25, was worth 99,630. In this transaction Director of this company bought 41,000 shares at a rate of $2.43, taking the stock ownership to the 41,000 shares. Before that another transaction happened on Sep 22 ’25, when Company’s Director bought 20,000 for $2.43, making the entire transaction worth $48,600. This insider now owns 20,000 shares in total.
Jasper Therapeutics Inc (JSPR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 10.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.38% during the next five years compared to 54.53% growth over the previous five years of trading.
Jasper Therapeutics Inc (NASDAQ: JSPR) Trading Performance Indicators
Check out the current performance indicators for Jasper Therapeutics Inc (JSPR). In the past quarter, the stock posted a quick ratio of 2.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.02, a number that is poised to hit -1.19 in the next quarter and is forecasted to reach -3.05 in one year’s time.
Technical Analysis of Jasper Therapeutics Inc (JSPR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.56 million. That was better than the volume of 0.48 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.88%.
During the past 100 days, Jasper Therapeutics Inc’s (JSPR) raw stochastic average was set at 5.13%, which indicates a significant decrease from 56.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was lower than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.79, while its 200-day Moving Average is $6.20. However, in the short run, Jasper Therapeutics Inc’s stock first resistance to watch stands at $2.56. Second resistance stands at $2.64. The third major resistance level sits at $2.79. If the price goes on to break the first support level at $2.32, it is likely to go to the next support level at $2.17. Assuming the price breaks the second support level, the third support level stands at $2.09.
Jasper Therapeutics Inc (NASDAQ: JSPR) Key Stats
There are currently 16,253K shares outstanding in the company with a market cap of 68.97 million. Presently, the company’s annual sales total 0 K according to its annual income of -71,270 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -26,720 K.
